GlassScriptPhysician profile
Katherine A Minor
NPI 1598998890
$76,326.75
in general payments reported to CMS, 2019-2025
32 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18K · 2022: $23K · 2023: $14K · 2024: $11K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Food and Beverage: $5,594 · Travel and Lodging: $3,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,070.00 |
| Food and Beverage | $5,594.34 |
| Travel and Lodging | $3,484.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $40,074.37 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31,424.82 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,164.53 | 2021-2025 | |
| Atricure, INC. | $405.77 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $342.77 | 2021-2024 | Verquvo |
| Cvrx, INC. | $299.78 | 2021-2023 | Barostim Neo System |
| Pfizer INC. | $284.64 | 2022-2025 | |
| Medtronic, INC. | $200.25 | 2021-2025 | Aquamantys(Tm) |
| Actelion Pharmaceuticals US, INC. | $194.68 | 2022-2025 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $192.03 | 2021-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $190.50 | 2024-2025 | Wegovy, Ozempic |
| Amgen INC. | $175.73 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $175.38 | 2021-2024 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $153.71 | 2021-2024 | Farxiga, Wainua |
| Alnylam Pharmaceuticals INC. | $150.01 | 2021-2025 | Amvuttra |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.20 | 2023-2025 | Jardiance |
| Kiniksa Pharmaceuticals, LTD. | $99.12 | 2022-2023 | Arcalyst |
| Abbott Laboratories | $96.15 | 2021-2023 | Assurity |
| Cleerly, INC. | $89.85 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Itamar Medical INC | $83.19 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $80.75 | 2023-2024 | Inpefa |
| Heartflow, INC. | $59.75 | 2024 | |
| Sanofi-Aventis U.S. LLC | $59.25 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $36.43 | 2024 | Arcalyst |
| Lilly USA, LLC | $33.61 | 2025 | Zepbound, Mounjaro |
| Bridgebio Pharma, INC. | $30.86 | 2025 | Attruby |
| Daiichi Sankyo INC. | $27.84 | 2023 | Injectafer |
| Impulse Dynamics (USA) INC. | $20.45 | 2022 | |
| Philips North America LLC | $19.63 | 2022 | |
| Bardy Diagnostics, INC. | $14.41 | 2022 | |
| Amarin Pharma, INC. | $14.29 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Minor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.